Will O'Connor: Covid-19 is the 9/11 moment for healthcare

April 12, 2020 00:24:06
Will O'Connor: Covid-19 is the 9/11 moment for healthcare
The Big Unlock
Will O'Connor: Covid-19 is the 9/11 moment for healthcare

Apr 12 2020 | 00:24:06

/

Show Notes

In this episode, Will O’ Connor, Chief Medical Information Officer of TigerConnect discusses their company structure, the marketplace they are servicing, and challenges healthcare enterprises are facing in response to the Covid-19 pandemic. TigerConnect is a clinical collaboration and communication platform and serves around 6000 customers across the world.   Due to the ongoing crisis, healthcare providers are witnessing a massive uptick in telehealth and virtual care. Dr. O’Connor states that in the last 2-3 weeks there has been 10 to 15 years of advancement in telehealth both in terms of policy and in practice. The company saw a growth in their messaging platform from 5 million to 6 million in just ten days.   Dr. O’Connor hopes that after Covid-19, care delivery will undergo a permanent sea change. The notion of delivering quality of care to patients who can be managed remotely will stay with us for a long time. Take a listen.

Other Episodes

Episode 0

February 22, 2021 00:26:04
Episode Cover

Katherine Lusk: Our focus for virtual health is making sure encounters are documented in such a way that it is not burdensome

In this episode, Katherine Lusk discusses how AHIMA works at the intersection of healthcare and technology to empower patients with their health information, and...

Listen

Episode 0

August 07, 2020 00:23:30
Episode Cover

Sara Vaezy: COVID-19 has given us an opportunity to reset and create a better healthcare system

In this episode, Sara Vaezy, Chief Digital Strategy & Business Development Officer of Providence Health talks about their recently published series of reports – ...

Listen

Episode 0

September 23, 2025 00:27:36
Episode Cover

AI Innovation Across Healthcare and Pharma

The Big Unlock · Thomas Fuchs, Chief AI Officer, Eli Lilly and Company In this episode, Thomas Fuchs, Chief AI Officer at Eli Lilly,...

Listen